Key result
Tai Chi combined with conventional medication significantly improved quality of life, exercise capacity, and left ventricular ejection fraction compared to conventional medication alone in adults with chronic heart failure, though overall evidence quality was low.
Why the study?
Tai chi is popular among adults with chronic heart failure yet services remain underutilized, prompting an overview to summarize evidence and evaluate its clinical effectiveness.
Does Tai Chi combined with conventional medication improve exercise capacity, quality of life, and cardiac function in adults with chronic heart failure?
Systematic Review
Does Tai Chi combined with conventional medication improve exercise capacity, quality of life, and cardiac function in adults with chronic heart failure?
Tai Chi may be a promising complementary treatment to improve quality of life and exercise capacity in patients with chronic heart failure, but current evidence is limited by the low methodological quality of existing systematic reviews.
May support Tai Chi as adjunctive therapy in chronic heart failure; leaves open confirmation by higher-quality trials.
Background: Tai chi (TC) is a popular form of exercise among adults with chronic heart failure (CHF), yet services are greatly underutilized. The aim of the current study was to identify and summarize the existing evidence and to systematically determine the clinical effectiveness of Tai Chi in the management of CHF using a systematic overview. Methods: Both English and Chinese databases were searched for systematic reviews (SRs)/meta-analyses (MAs) on TC for CHF from their inception to June 2020. The methodological quality, reporting quality, and risk of bias of SRs/MAs were assessed using Assessing the Methodological Quality of Systematic Reviews 2 (AMSTAR-2), the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist, and Risk of Bias in Systematic reviews (ROBIS), respectively. The evidence quality of outcome measures was assessed by the Grades of Recommendations, Assessment, Development and Evaluation (GRADE). Results: Six SRs/MAs using a quantitative synthesis to assess various outcomes of TC in CHF were included in this overview. The methodological quality, reporting quality and risk of bias of the SRs/MAs and the evidence quality of the outcome measures are generally unsatisfactory. The limitations of the past SRs/MAs included the lack of either the protocol or registration, the list of excluded studies, and the computational details of meta-analysis were inadequately reported. The critical problems were that qualitative data synthesis relied on trials with small sample sizes and critical low quality. Conclusions: TC may be a promising complementary treatment for CHF. However, further rigorous and comprehensive SRs/MAs and RCTs are required to provide robust evidence for definitive conclusions.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2021) conducted a systematic review in Chronic heart failure. Tai Chi vs. Conventional medication alone was evaluated on Quality of life, exercise capacity (6MWD), BNP, and LVEF. Tai Chi combined with conventional medication significantly improved quality of life, exercise capacity, and left ventricular ejection fraction compared to conventional medication alone in adults with chronic heart failure, though overall evidence quality was low.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: